Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera for chronic renal anaemia in dialysis patients
NCT01066000Phase 4Terminated
- Sponsor
- Roche
- Start
- Oct 2009
- Primary completion
- Sep 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of methoxy polyethylene glycol-epoetin beta in anemia, sponsored by Roche. Started Oct 2009; status: terminated.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01066000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066000.